Phocea, Pseudoflavonifractor and Lactobacillus intestinalis: Three Potential Biomarkers of Gut Microbiota That Affect Progression and Complications of Obesity-Induced Type 2 Diabetes Mellitus

References

• Wu YL, Ding YP, Tanaka Y, Zhang W. Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention. Int J Med Sci. 2014;11(11):1185–1200. doi:10.7150/ijms.10001
   PubMed Web of Science ®Google Scholar
• Cho NH, Shaw JE, Karuranga S, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–281. doi:10.1016/j.diabres.2018.02.023
   PubMed Web of Science ®Google Scholar
• Ahmed KA, Muniandy S, Ismail IS. Type 2 diabetes and vascular complications: a pathophysiologic view. Biomed Res. 2010;21(2):147–155.
   Google Scholar
• Shulman GI. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. New Engl J Med. 2014;371(23):2241.
   Google Scholar
• Larsen N, Vogensen FK, van den Berg FWJ, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One. 2010;5(2):2. doi:10.1371/journal.pone.0009085
   Google Scholar
• Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A. 2005;102(31):11070–11075. doi:10.1073/pnas.0504978102
   PubMed Web of Science ®Google Scholar
• Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core gut microbiome in obese and lean twins. Nature. 2009;457(7228):480–U487. doi:10.1038/nature07540
   PubMed Web of Science ®Google Scholar
• Karlsson FH, Tremaroli V, Nookaew I, et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 2013;498(7452):99-+. doi:10.1038/nature12198
   PubMedGoogle Scholar
• Qin JJ, Li YR, Cai ZM, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490(7418):55–60. doi:10.1038/nature11450
   PubMed Web of Science ®Google Scholar
• Tremaroli V, Backhed F. Functional interactions between the gut microbiota and host metabolism. Nature. 2012;489(7415):242–249. doi:10.1038/nature11552
   PubMed Web of Science ®Google Scholar
• Lydic TA, Goo YH. Lipidomics unveils the complexity of the lipidome in metabolic diseases. Clin Transl Med. 2018;7(1):4.
   PubMedGoogle Scholar
• Wang TJ, Larson MG, Vasan RS, et al. Metabolite profiles and the risk of developing diabetes. Nat Med. 2011;17(4):448–453. doi:10.1038/nm.2307
   PubMed Web of Science ®Google Scholar
• Guasch-Ferre M, Hruby A, Toledo E, et al. Metabolomics in prediabetes and diabetes: a systematic review and meta-analysis. Diabetes Care. 2016;39(5):833–846. doi:10.2337/dc15-2251
   PubMed Web of Science ®Google Scholar
• Markgraf DF, Al-Hasani H, Lehr S. Lipidomics-reshaping the analysis and perception of type 2 diabetes. Int J Mol Sci. 2016;17(11):11. doi:10.3390/ijms17111841
   Google Scholar
• Denery JR, Nunes AAK, Dickerson TJ. Characterization of differences between blood sample matrices in untargeted metabolomics. Anal Chem. 2011;83(3):1040–1047. doi:10.1021/ac102806p
   PubMedGoogle Scholar
• Vance JE, Vance DE. Biochemistry of Lipids, Lipoproteins and Membranes. Elsevier; 2008.
   Google Scholar
• Phillips MS, Liu QY, Hammond HA, et al. Leptin receptor missense mutation in the fatty Zucker rat. Nat Genet. 1996;13(1):18–19. doi:10.1038/ng0596-18
   PubMed Web of Science ®Google Scholar
• Srinivasan K, Ramarao P. Animal models in type 2 diabetes research: an overview. Indian J Med Res. 2007;125(3):451–472.
   PubMed Web of Science ®Google Scholar
• Peterson RG, Shaw WN, Neel MA, Little LA, Eichberg J. Zucker diabetic fatty rat as a model for non-insulin-dependent diabetes mellitus. ILAR J. 1990;32(3):16–19. doi:10.1093/ilar.32.3.16
   Google Scholar
• Yokoi N, Hoshino M, Hidaka S, et al. A novel rat model of type 2 diabetes: the Zucker fatty diabetes mellitus ZFDM rat. J Diabetes Res. 2013;2013:103731. doi:10.1155/2013/103731
   PubMed Web of Science ®Google Scholar
• Zhou W, Xu HY, Zhan LB, Lu XG, Zhang LJ. Dynamic development of fecal microbiome during the progression of diabetes mellitus in Zucker diabetic fatty rats. Front Microbiol. 2019;10:232.
   PubMedGoogle Scholar
• Bando K, Kawahara R, Kunimatsu T, et al. Influences of biofluid sample collection and handling procedures on GC-MS based metabolomic studies. J Biosci Bioeng. 2010;110(4):491–499. doi:10.1016/j.jbiosc.2010.04.010
   PubMedGoogle Scholar
• Dunn WB, Broadhurst D, Begley P, et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc. 2011;6(7):1060–1083. doi:10.1038/nprot.2011.335
   PubMed Web of Science ®Google Scholar
• Pereira H, Martin JF, Joly C, Sebedio JL, Pujos-Guillot E. Development and validation of a UPLC/MS method for a nutritional metabolomic study of human plasma. Metabolomics. 2010;6(2):207–218. doi:10.1007/s11306-009-0188-9
   Google Scholar
• Beckonert O, Keun HC, Ebbels TMD, et al. Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc. 2007;2(11):2692–2703. doi:10.1038/nprot.2007.376
   PubMed Web of Science ®Google Scholar
• Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 2011;17(1):10–12. doi:10.14806/ej.17.1
   Google Scholar
• Quast C, Pruesse E, Yilmaz P, et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 2013;41(Database issue):D590–D596. doi:10.1093/nar/gks1219
   PubMed Web of Science ®Google Scholar
• Haas BJ, Gevers D, Earl AM, et al. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res. 2011;21(3):494–504. doi:10.1101/gr.112730.110
   PubMed Web of Science ®Google Scholar
• Lappas M, Mundra PA, Wong G, et al. The prediction of type 2 diabetes in women with previous gestational diabetes mellitus using lipidomics. Diabetologia. 2015;58(7):1436–1442. doi:10.1007/s00125-015-3587-7
   PubMed Web of Science ®Google Scholar
• Floegel A, Stefan N, Yu ZH, et al. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes. 2013;62(2):639–648. doi:10.2337/db12-0495
   PubMed Web of Science ®Google Scholar
• Bray GA, Heisel WE, Afshin A, et al. The science of obesity management: an endocrine society scientific statement. Endocr Rev. 2018;39(2):79–132.
   PubMed Web of Science ®Google Scholar
• Wilson PWF, D’Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk - The Framingham experience. Arch Intern Med. 2002;162(16):1867–1872. doi:10.1001/archinte.162.16.1867
   PubMedGoogle Scholar
• Fabbiano S, Suarez-Zamorano N, Chevalier C, et al. Functional gut microbiota remodeling contributes to the caloric restriction-induced metabolic improvements. Cell Metab. 2018;28(6):907–921 e907. doi:10.1016/j.cmet.2018.08.005
   PubMed Web of Science ®Google Scholar
• Hildebrandt MA, Hoffmann C, Sherrill-Mix SA, et al. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology. 2009;137(5):1716–1724 e1711-1712. doi:10.1053/j.gastro.2009.08.042
   PubMed Web of Science ®Google Scholar
• Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444(7122):1027–1031. doi:10.1038/nature05414
   PubMed Web of Science ®Google Scholar
• Kahn BB, Alquier T, Carling D, Hardie DG. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 2005;1(1):15–25. doi:10.1016/j.cmet.2004.12.003
   PubMed Web of Science ®Google Scholar
• Hu Y, Peng J, Li F, Wong FS, Wen L. Evaluation of different mucosal microbiota leads to gut microbiota-based prediction of type 1 diabetes in NOD mice. Sci Rep. 2018;8(1):15451. doi:10.1038/s41598-018-33571-z
   PubMed Web of Science ®Google Scholar
• Cho I, Blaser MJ. The human microbiome: at the interface of health and disease. Nat Rev Genet. 2012;13(4):260–270. doi:10.1038/nrg3182
   PubMed Web of Science ®Google Scholar
• Kameyama K, Itoh K. Intestinal colonization by a Lachnospiraceae bacterium contributes to the development of diabetes in obese mice. Microbes Environ. 2014;29(4):427–430. doi:10.1264/jsme2.ME14054
   PubMed Web of Science ®Google Scholar
• Liu B, Zhang Y, Wang R, et al. Western diet feeding influences gut microbiota profiles in apoE knockout mice. Lipids Health Dis. 2018;17(1):159. doi:10.1186/s12944-018-0811-8
   PubMedGoogle Scholar
• Wang Y, Luo X, Mao X, et al. Gut microbiome analysis of type 2 diabetic patients from the Chinese minority ethnic groups the Uygurs and Kazaks. PLoS One. 2017;12(3):e0172774. doi:10.1371/journal.pone.0172774
   PubMed Web of Science ®Google Scholar
• Gomez-Arango LF, Barrett HL, McIntyre HD, et al. Connections between the gut microbiome and metabolic hormones in early pregnancy in overweight and obese women. Diabetes. 2016;65(8):2214–2223. doi:10.2337/db16-0278
   PubMed Web of Science ®Google Scholar
• Bhute SS, Suryavanshi MV, Joshi SM, Yajnik CS, Shouche YS, Ghaskadbi SS. Gut microbial diversity assessment of indian type-2-diabetics reveals alterations in Eubacteria, Archaea, and Eukaryotes. Front Microbiol. 2017;8:214.
   PubMedGoogle Scholar
• Huang SL, Mao J, Zhou L, Xiong X, Deng YQ. The imbalance of gut microbiota and its correlation with plasma inflammatory cytokines in pemphigus vulgaris patients. Scand J Immunol. 2019;90(3). doi:10.1111/sji.2019.90.issue-3
   Google Scholar
• Dong YH, Cheng HM, Liu Y, Xue ML, Liang H. Red yeast rice ameliorates high-fat diet-induced atherosclerosis in Apoe(-/-) mice in association with improved inflammation and altered gut microbiota composition. Food Funct. 2019;10(7):3880–3889. doi:10.1039/C9FO00583H
   PubMed Web of Science ®Google Scholar
• He Z, Shao T, Li H, Xie Z, Wen C. Alterations of the gut microbiome in Chinese patients with systemic lupus erythematosus. Gut Pathog. 2016;8(1):64. doi:10.1186/s13099-016-0146-9
   PubMedGoogle Scholar
• Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science. 1996;271(5249):665–668. doi:10.1126/science.271.5249.665
   PubMed Web of Science ®Google Scholar
• Ehses JA, Perren A, Eppler E, et al. Increased number of islet-associated macrophages in type 2 diabetes. Diabetes. 2007;56(9):2356–2370. doi:10.2337/db06-1650
   PubMed Web of Science ®Google Scholar
• Sakamoto M, Iino T, Yuki M, Ohkuma M. Lawsonibacter asaccharolyticus gen. nov., sp. nov., a butyrate-producing bacterium isolated from human faeces. Int J Syst Evol Microbiol. 2018;68(6):2074–2081. doi:10.1099/ijsem.0.002800
   PubMedGoogle Scholar
• Ferrocino I, Ponzo V, Gambino R, et al. Changes in the gut microbiota composition during pregnancy in patients with gestational diabetes mellitus (GDM). Sci Rep-Uk. 2018;8(1):1–3.
   PubMedGoogle Scholar
• Kashtanova DA, Tkacheva ON, Doudinskaya EN, et al. Gut microbiota in patients with different metabolic statuses: Moscow Study. Microorganisms. 2018;6(4):98. doi:10.3390/microorganisms6040098
   PubMed Web of Science ®Google Scholar
• Gerritsen J, Fuentes S, Grievink W, et al. Characterization of Romboutsia ilealis gen. nov., sp nov., isolated from the gastro-intestinal tract of a rat, and proposal for the reclassification of five closely related members of the genus Clostridium into the genera Romboutsia gen. nov., Intestinibacter gen. nov., Terrisporobacter gen. nov and Asaccharospora gen. nov. Int J Syst Evol Micr. 2014;64:1600–1616.
   PubMedGoogle Scholar
• Liu J, Yue SJ, Yang ZR, et al. Oral hydroxysafflor yellow A reduces obesity in mice by modulating the gut microbiota and serum metabolism. Pharmacol Res. 2018;134:40–50. doi:10.1016/j.phrs.2018.05.012
   PubMed Web of Science ®Google Scholar
• Li TT, Tong AJ, Liu YY, et al. Polyunsaturated fatty acids from microalgae Spirulina platensis modulates lipid metabolism disorders and gut microbiota in high-fat diet rats. Food Chem Toxicol. 2019;131:110558.
   PubMed Web of Science ®Google Scholar
• Hua PP, Yu ZY, Xiong Y, Liu B, Zhao LN. Regulatory efficacy of Spirulina platensis protease hydrolyzate on lipid metabolism and gut microbiota in high-fat diet-fed rats. Int J Mol Sci. 2018;19(12):4023. doi:10.3390/ijms19124023
   PubMedGoogle Scholar
• Wan XZ, Li TT, Liu D, et al. Effect of Marine Microalga chlorella pyrenoidosa ethanol extract on lipid metabolism and gut microbiota composition in high-fat diet-fed rats. Mar Drugs. 2018;16(12):498. doi:10.3390/md16120498
   PubMedGoogle Scholar
• Han LH, Li TG, Du M, Chang R, Zhan BY, Mao XY. Beneficial effects of potentilla discolor bunge water extract on inflammatory cytokines release and gut microbiota in high-fat diet and streptozotocin-induced type 2 diabetic mice. Nutrients. 2019;11(3):670. doi:10.3390/nu11030670
   PubMed Web of Science ®Google Scholar
• Sato J, Kanazawa A, Ikeda F, et al. Gut dysbiosis and detection of “live gut bacteria” in blood of Japanese patients with type 2 diabetes. Diabetes Care. 2014;37(8):2343–2350. doi:10.2337/dc13-2817
   PubMed Web of Science ®Google Scholar
• Wang C, Kong HW, Guan YF, et al. Plasma phospholipid metabolic profiling and biomarkers of type 2 diabetes mellitus based on high-performance liquid chromatography/electrospray mass spectrometry and multivariate statistical analysis. Anal Chem. 2005;77(13):4108–4116. doi:10.1021/ac0481001
   PubMed Web of Science ®Google Scholar
• Schaap FG, Trauner M, Jansen PLM. Bile acid receptors as targets for drug development. Nat Rev Gastroenterol Hepatol. 2014;11(1):55–67. doi:10.1038/nrgastro.2013.151
   PubMed Web of Science ®Google Scholar
• Zhai HN, Li Z, Peng MA, et al. Takeda G protein-coupled receptor 5-mechanistic target of rapamycin complex 1 signaling contributes to the increment of glucagon-like peptide-1 production after Roux-en-Y gastric bypass. Ebiomedicine. 2018;32:201–214. doi:10.1016/j.ebiom.2018.05.026
   PubMedGoogle Scholar
• Zhang Y, Edwards PA. FXR signaling in metabolic disease. FEBS Lett. 2008;582(1):10–18. doi:10.1016/j.febslet.2007.11.015
   PubMed Web of Science ®Google Scholar
• Prattichizzo F, De Nigris V, Spiga R, et al. Inflammageing and metaflammation: the yin and yang of type 2 diabetes. Ageing Res Rev. 2018;41:1–17. doi:10.1016/j.arr.2017.10.003
   PubMed Web of Science ®Google Scholar
• Sun L, Xie C, Wang G, et al. Gut microbiota and intestinal FXR mediate the clinical benefits of metformin. Nat Med. 2018;24(12):1919–1929. doi:10.1038/s41591-018-0222-4
   PubMed Web of Science ®Google Scholar
• Duran-Sandoval D, Cariou B, Percevault F, et al. The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition. J Biol Chem. 2005;280(33):29971–29979. doi:10.1074/jbc.M501931200
   PubMedGoogle Scholar
• Cariou B, van Harmelen K, Duran-Sandoval D, et al. Transient impairment of the adaptive response to fasting in FXR-deficient mice. FEBS Lett. 2005;579(19):4076–4080. doi:10.1016/j.febslet.2005.06.033
   PubMedGoogle Scholar
• Jia W, Xie GX, Jia WP. Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nat Rev Gastroenterol Hepatol. 2018;15(2):111–128. doi:10.1038/nrgastro.2017.119
   PubMed Web of Science ®Google Scholar
• Moreno-Navarrete JM, Serino M, Blasco-Baque V, et al. Gut microbiota interacts with markers of adipose tissue browning, insulin action and plasma acetate in morbid obesity. Mol Nutr Food Res. 2018;62(3). doi:10.1002/mnfr.201700721
   Google Scholar